Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...

A new study published in the Pakistan Journal of Pharmaceutical Science showed that when used as an adjuvant treatment for diabetic foot ulcers or diabetic peripheral neuropathy caused by type ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process could help improve recovery ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

Peripheral nerve injury reduces the ability of macrophages to clear dead or dying cells – a process known as efferocytosis – leading to chronic pain Restoring efferocytosis ability reduced neuropathic ...

A hidden immune stress switch may be driving chemotherapy nerve pain and scientists have found a way to turn it off.

Nerve damage (neuropathy) occurs when nerves are injured, and can manifest through symptoms like tingling, numbness, burning ...

Our legs do much more than carry our entire body weight; they can also serve as a window to our health. Many health ...

Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...